Arstasis
Medical Devices, 740 Bay Road, Redwood City, California, 94063, United States, 51-200 Employees
Phone Number: 87********
Who is ARSTASIS
Self-Sealing Access, Implant Free… Naturally. AXERA® Access seals securely using nothing but the femoral artery wall itself. AXERA® Access creates a long, shallow angle arteriotomy tha...
Read More
-
Headquarters: 740 Bay Road, Redwood City, California, 94063, United States
-
Date Founded: 2004
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3829
|
NAICS Code: 339112 |
Show More
Arstasis Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Arstasis
Answer: Arstasis's headquarters are located at 740 Bay Road, Redwood City, California, 94063, United States
Answer: Arstasis's phone number is 87********
Answer: Arstasis's official website is https://arstasis.com
Answer: Arstasis's revenue is $25 Million to $50 Million
Answer: Arstasis's SIC: 3829
Answer: Arstasis's NAICS: 339112
Answer: Arstasis has 51-200 employees
Answer: Arstasis is in Medical Devices
Answer: Arstasis contact info: Phone number: 87******** Website: https://arstasis.com
Answer: Self-Sealing Access, Implant Free… Naturally. AXERA® Access seals securely using nothing but the femoral artery wall itself. AXERA® Access creates a long, shallow angle arteriotomy that delivers significant tissue-on-tissue overlap through the femoral artery wall. This creates a self-sealing opening that requires only minimal compression for rapid hemostasis and secure closure. Self-sealing access also provides excellent patient comfort and quick ambulation. And because AXERA® Access deposits no foreign material, it eliminates all implant related complications. Self-Sealing Access Benefits Demonstrated in RECITAL Study* - Significant decrease in manual compression time by half or more - Elevate bed to 45º within 15-30 minutes of hemostasis - Ambulate patients in 1 to 2 hours - No patient implant delivers excellent patient comfort and safety *AXERA 2 IFU, SECURE II and RECITAL clinical study summaries.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month